| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/26/2013 | CN103169955A Chinese herbal medicine composition for preventing and treating heat stress of chickens |
| 06/26/2013 | CN103169761A Effective part of traditional Chinese medicine compound Chinese angelica blood replenishing soup and synchronous preparation method and application thereof |
| 06/26/2013 | CN103169740A Valeriana jatamansi freeze-drying preparation and preparation method thereof |
| 06/26/2013 | CN103169682A Polysaccharide sulfate tablet and preparation method of polysaccharide sulfate tablet |
| 06/26/2013 | CN102512631B Chinese medicinal composition for treating jaundice |
| 06/26/2013 | CN101698024B Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof |
| 06/26/2013 | CN101505788B Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 06/26/2013 | CN101273123B Cell/ligand marking system, wherein the marker is of Eph type, cell material comprising the system, method for preparing same and proangiogenetic use |
| 06/25/2013 | US8470969 Apo-2 ligand/trail formulations |
| 06/25/2013 | US8470783 For treating prostate cancer and malignant lymphoma; gene expression inhibition |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | CA2725425C Homocysteine synthase inhibitor |
| 06/25/2013 | CA2692295C Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer |
| 06/25/2013 | CA2632842C Process for preparation of water-soluble azole prodrugs |
| 06/25/2013 | CA2627598C Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 06/25/2013 | CA2598988C Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
| 06/25/2013 | CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 06/25/2013 | CA2458798C Method for reducing hypertension and heart failure |
| 06/25/2013 | CA2454578C Modified human thymic stromal lymphopoietin |
| 06/25/2013 | CA2444894C Sustained release drug delivery system containing codrugs |
| 06/25/2013 | CA2407808C Cyclipostins, process for their preparation and use thereof |
| 06/25/2013 | CA2285241C Substituted 3-cyano quinolines |
| 06/20/2013 | WO2013090766A1 Uses of 3'-desferrithiocin analogs |
| 06/20/2013 | WO2013089212A1 Substituted triazine derivative and pharmaceutical composition containing same |
| 06/20/2013 | WO2013089140A1 Method for producing antimicrobial composition |
| 06/20/2013 | US20130158132 Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans |
| 06/20/2013 | US20130158092 New Oral Formulation |
| 06/20/2013 | US20130157965 Prevention and Treatment of Oxidative Stress Disorders by Glutathione and Phase II Detoxification Enzymes |
| 06/20/2013 | US20130156792 Uniform field magnetization and targeting of therapeutic formulations |
| 06/20/2013 | US20130156749 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/19/2013 | EP2604692A1 Immunology treatment for biofilms |
| 06/19/2013 | EP2604610A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
| 06/19/2013 | EP2604606A1 Inhibitor of casein kinase 1 and casein kinase 1 |
| 06/19/2013 | EP2604601A1 Hetero ring compound |
| 06/19/2013 | EP2604597A1 Heterocyclic compound and use thereof |
| 06/19/2013 | EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/19/2013 | EP2604290A2 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 06/19/2013 | EP2604270A1 Dextrin for suppressing elevation of blood alcohol concentration |
| 06/19/2013 | EP2604263A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma |
| 06/19/2013 | EP2604261A2 SCCA-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient |
| 06/19/2013 | CN1950343B Basic amine compound and use thereof |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103167865A Collagen production promoter, hyaluronan production promoter, fibroblast proliferation promoter, and anti-wrinkle agent |
| 06/19/2013 | CN103160569A Discovery for new mechanism for regulating dynamic state of cell microfilaments |
| 06/19/2013 | CN103156931A Plaster for treating hyperhidrosis |
| 06/19/2013 | CN103156841A Compound of 17-hydrogen-9-dehydrogenation andrographolide-3-sulphate sodium (or potassium) and 17-hydrogen-9-dehydrogenation andrographolide-19-sulphate sodium (or potassium) and preparation drug purposes thereof |
| 06/19/2013 | CN103156840A Once preparation method of composite of 17-hydrogen-9-dehydro-andrographolidume-3-sodium (or potassium) disulfate and 17-hydrogen-9-dehydro-andrographolidume-3, 19-sodium (or potassium) disulfate, and purposes of prepared medicine |
| 06/19/2013 | CN102688173B Traditional Chinese medicine bath foam |
| 06/19/2013 | CN102101854B Benzomacrolide compounds having pancrelipase inhibiting activity and synthesis method and use thereof |
| 06/19/2013 | CN101910189B Monosebacate of pyrazole derivative |
| 06/19/2013 | CN101678082B Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies |
| 06/19/2013 | CN101602730B Substituted imidazole derivative |
| 06/19/2013 | CN101486701B Analogue compound, and analogue and medical use thereof |
| 06/19/2013 | CN101486700B 8-acetyl chromanone compound, and analogue and medical use thereof |
| 06/19/2013 | CN101466835B Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 06/19/2013 | CN101316930B T-cell adhesion molecule and antibody directed against the molecule |
| 06/18/2013 | USRE44302 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466146 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 06/18/2013 | US8465758 Drug delivery from stents |
| 06/18/2013 | CA2475923C Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 06/18/2013 | CA2468463C Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2446087C Recombinant tumor specific antibody and use thereof |
| 06/18/2013 | CA2267077C Methods for treating skin pigmentation |
| 06/13/2013 | WO2013085059A1 Method for producing nutritional composition |
| 06/13/2013 | WO2013085018A1 Phenylpyrrole derivative |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084971A1 Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof |
| 06/13/2013 | WO2013083994A1 Hydantoin derivatives useful as kv3 inhibitors |
| 06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130149334 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/13/2013 | US20130149299 Dosages for treatment with anti-egfr antibodies |
| 06/13/2013 | CA2858342A1 Phenylpyrrole derivative |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2856654A1 Hydantoin derivatives useful as kv3 inhibitors |
| 06/12/2013 | EP2602260A1 Process for preparing compound having hiv integrase inhibitory activity |
| 06/12/2013 | EP2602259A2 Salt of proline derivative, solvate thereof, and production method thereof |
| 06/12/2013 | EP2602255A1 Fused heterocyclic ring compound |
| 06/12/2013 | EP2602242A1 Process for preparing compound by novel sandmeyer-like reaction using nitroxide radical compound as reaction catalyst |
| 06/12/2013 | EP2601971A1 Composition for regeneratng normal tissue from fibrotic tissue |
| 06/12/2013 | EP2601959A1 Elastase inhibitor |
| 06/12/2013 | EP2601956A1 Islets of langerhans transplant using islets of langerhans and adipose tissue derived stem cells |
| 06/12/2013 | EP2601949A2 Pharmaceutical compositions |
| 06/12/2013 | EP2601948A1 Preparation for treatment of spinal cord injury |
| 06/12/2013 | EP2600901A2 Engineered nucleic acids and methods of use thereof |
| 06/12/2013 | EP2600862A2 Inhibitors of erk for developmental disorders of neuronal connectivity |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN1525857B Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 06/12/2013 | CN103154004A Process for preparing compound having HIV integrase inhibitory activity |
| 06/12/2013 | CN103153977A Organic amine salt of aminobenzoic acid derivative, and method for producing same |
| 06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/12/2013 | CN103145836A Anti-myostatin single-chain antibody, and its coding gene, expression vector, recombinant transformant and application |
| 06/12/2013 | CN103143055A Use of adipose tissue-derived stromal stem cells in treating fistula |
| 06/12/2013 | CN103142473A Composition containing high purity bilobalide B and preparation method thereof |